Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats

被引:79
作者
Kosasa, T [1 ]
Kuriya, Y [1 ]
Matsui, K [1 ]
Yamanishi, Y [1 ]
机构
[1] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3002635, Japan
关键词
donepezil hydrochloride; E2020; acetylcholinesterase inhibitor; acetylcholine; microdialysis; tacrine; ENA-713;
D O I
10.1016/S0014-2999(99)00545-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of oral administration of the centrally acting acetylcholinesterase (AChE) inhibitors, donepezil hydrochloride (donepezil: E2020: (+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-indan-1-one monohydrochloride), tacrine (9-amino-1,2,3,4-tetrahydroacridine hydrochloride) and ENA-713 (rivastigmine: (S)-N-ethyl-3-[(1-dimethyl-amino)ethyl]-N-methyl-phenylcarbamate hydrogentartrate), which have been developed for the treatment of Alzheimer's disease, on the extracellular acetylcholine concentration in the hippocampus of rats were evaluated by using a microdialysis technique without adding cholinesterase inhibitor to the perfusion solution. We also compared the inhibition of brain AChE and the brain concentrations of these drugs. Donepezil at 2.5 mg/kg and tacrine at 5 mg/kg showed significant effects for more than 6 h. At these doses, the maximum increases were observed at about 1.5 h after administration of donepezil, and at about 2 h with tacrine, and were 499% and 422% of the pre-level, respectively. ENA-713 produced significant effects at doses of 0.625, 1.25 and 2.5 mg/kg, which lasted for about 1, 2 and 4 h, respectively. The maximum increases produced by these doses at about 0.5 h after administration were 190, 346 and 458% of the pre-level, respectively. The time courses of brain AChE inhibition with donepezil at 2.5 mg/kg, tacrine at 10 mg/kg and ENA-713 at 2.5 mg/kg were mirror images of the extracellular acetylcholine-increasing action at the same doses. The time courses of the brain concentrations of drugs after oral administration of donepezil at 2.5 mg/kg and tacrine at 10 mg/kg were consistent with those of brain AChE inhibition at the same doses, and there was a linear relation between these parameters. Brain concentration of ENA-713 at 2.5 mg/kg was below the limit of quantification at all time points measured. These results suggest that oral administration of donepezil, tacrine and ENA-713 increases acetylcholine concentration in the synaptic cleft of the hippocampus mostly through AChE inhibition, and that donepezil has a more potent activity than tacrine and a longer-lasting effect than ENA-713 on the central cholinergic system. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 20 条
  • [1] Anand R, 1996, J DRUG DEV CLIN PR, V8, P109
  • [2] BEERMANN B, 1993, ACTA NEUROL SCAND, V88, P53
  • [3] The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex
    Giacobini, E
    Zhu, XD
    Williams, E
    Sherman, KA
    [J]. NEUROPHARMACOLOGY, 1996, 35 (02) : 205 - 211
  • [4] EFFECT OF NIK-247 ON BASAL CONCENTRATIONS OF EXTRACELLULAR ACETYLCHOLINE IN THE CEREBRAL-CORTEX OF CONSCIOUS, FREELY MOVING RATS
    ISHII, Y
    KOJIMA, J
    IKEDA, N
    KAWASHIMA, K
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1994, 66 (03) : 289 - 293
  • [5] KAWASHIMA K, 1994, N-S ARCH PHARMACOL, V350, P523
  • [6] CHOLINESTERASE INHIBITOR EFFECTS ON EXTRACELLULAR ACETYLCHOLINE IN RAT CORTEX
    MESSAMORE, E
    WARPMAN, U
    OGANE, N
    GIACOBINI, E
    [J]. NEUROPHARMACOLOGY, 1993, 32 (08) : 745 - 750
  • [7] OGURA H, 1988, Society for Neuroscience Abstracts, V14, P60
  • [8] SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats
    Ohara, T
    Tanaka, K
    Fukaya, H
    Demura, N
    Iimura, A
    Seno, N
    [J]. BEHAVIOURAL BRAIN RESEARCH, 1997, 83 (1-2) : 229 - 233
  • [9] ROGENOS G, 1986, RAT BRAIN STEREOTAXI
  • [10] Rogers S.L., 1991, Advances in Alzheimer Disease Therapy, P314, DOI [10.1007/978-1-4899-6738-1_33, DOI 10.1007/978-1-4899-6738-1_33]